iSOFT said the move follows a co-marketing agreement with US-based CliniWorks for its AccelFind solutions.
CliniWorks has developed the technology behind AccelFind, and provides it as a service, to extract medical knowledge from any type of data, including free text notes, discharge summaries or the structured data contained in electronic medical records and laboratory systems.
With the new agreement, iSOFT will market AccelFind as part of its Life Science Solution ‘powered by CliniWorks’ to hospitals and life science companies worldwide and the benefits generated from the projects will be shared between the companies.
The Life Sciences Solution, will also be integrated with CordMatch and provide a tool allowing the secondary use of electronic health records, for clinical development, adding value for pharmaceutical companies and improves therapy quality and fostering personalized medicine.
Cytolon supports and participates in clinical research studies for the development of future applications of stem cell products derived from umbilical cord blood for a variety of diseases.
The iSOFT Life Sciences Solutions integrates with all standard hospital databases to extract clinical information and so promotes knowledge collaboration for highly efficient clinical research, outcomes tracking and management.
iSOFT chief medical officer Michael Dahlweid said Life Sciences is a new strategic asset of the company’s solution portfolio with a huge growth potential and perfectly fits their Smart Solution approach, which provides instant value to existing and new customers.
